Does PALBOCICLIB Cause Nasopharyngitis? 1,340 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,340 reports of Nasopharyngitis have been filed in association with PALBOCICLIB (Ibrance). This represents 1.5% of all adverse event reports for PALBOCICLIB.
1,340
Reports of Nasopharyngitis with PALBOCICLIB
1.5%
of all PALBOCICLIB reports
40
Deaths
195
Hospitalizations
How Dangerous Is Nasopharyngitis From PALBOCICLIB?
Of the 1,340 reports, 40 (3.0%) resulted in death, 195 (14.6%) required hospitalization, and 5 (0.4%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which PALBOCICLIB Alternatives Have Lower Nasopharyngitis Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID